UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION

                     Washington, D. C. 20549

                          _____________

                            FORM 8-K

                         CURRENT REPORT

             Pursuant to Section 13 or 15(d) of the

                 Securities Exchange Act of 1934


Date of earliest event
  reported:  November 17, 2005


                           AMR CORPORATION
     (Exact name of registrant as specified in its charter)


            Delaware               1-8400           75-1825172
(State of Incorporation) (Commission File Number) (IRS Employer
                                                Identification No.)


4333 Amon Carter Blvd.      Fort Worth, Texas           76155
 (Address of principal executive offices)            (Zip Code)


                         (817) 963-1234
                (Registrant's telephone number)



   (Former name or former address, if changed since last report.)



Check  the  appropriate  box below if  the  Form  8-K  filing  is
intended to simultaneously satisfy the filing obligation  of  the
registrant under any of the following provisions:

[ ]  Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))








Item 1.01.  Entry into a Material Definitive Agreement.

On  November 17, 2005, AMR Corporation (the Company) entered into
an  Underwriting Agreement (the Underwriting Agreement) with  UBS
Securities  LLC  (the Underwriter) relating to the  issuance  and
sale  of 13,000,000 (the 11/17/05 Shares) shares of the Company's
common stock, par value $1.00 per share (the Common Stock), at an
offering  price to the public of $17.25 per share.   The  Company
has  granted  the  Underwriter a 30-day  option  to  purchase  an
additional  1,950,000 shares of Common Stock (together  with  the
11/17/05 Shares, the Shares), at the same price per share paid to
the Company for the 11/17/05 Shares, to cover over-allotments, if
any.   The closing of the offering, which is subject to customary
closing conditions, is expected to occur on November 23, 2005.

The  shares  of  Common  Stock will be  issued  pursuant  to  the
Company's   shelf   registration  statement   (the   Registration
Statement)  on Form S-3 (File Nos. 333-110760 and 333-110760-01),
which  was  declared  effective by the  Securities  and  Exchange
Commission on December 17, 2003.

The  Underwriting  Agreement is filed  as  Exhibit  1.1  to  this
Current Report on Form 8-K (this report), and the description  of
the material terms of the Underwriting Agreement is qualified  in
its  entirety by reference to such exhibit.  For a more  detailed
description  of  the Underwriting Agreement, see  the  disclosure
under  the  caption  "Underwriting" contained  in  the  Company's
Prospectus  Supplement dated November 17, 2005 to the  Prospectus
dated  December 17, 2003, each of which has been filed  with  the
Securities and Exchange Commission pursuant to Rule 424(b)  under
the  Securities  Act, which disclosure is hereby incorporated  by
reference.   The  Underwriting  Agreement  is  also  filed   with
reference  to, and is hereby incorporated by reference into,  the
Registration  Statement.  A copy of the opinion  of  Debevoise  &
Plimpton LLP, relating to the legality of the Shares is filed  as
Exhibit 5.1 to this report and is filed with reference to, and is
hereby   incorporated   by  reference  into,   the   Registration
Statement.   A  copy of the opinion of Debevoise &  Plimpton  LLP
relating  to  certain tax matters with respect to the  Shares  is
filed  as  Exhibit 8.1 to this report and is filed with reference
to,   and   is  hereby  incorporated  by  reference   into,   the
Registration Statement.


Item 9.01.  Financial Statements and Exhibits.

      (d) Exhibits

     1.1  Underwriting Agreement dated November 17, 2005 between AMR
          Corporation and UBS Securities LLC

     5.1  Opinion of Debevoise & Plimpton LLP

     8.1  Opinion of Debevoise & Plimpton LLP

    23.1  Consent  of  Debevoise & Plimpton LLP  (contained  in
          Exhibit 5.1)

    23.2  Consent  of  Debevoise & Plimpton LLP  (contained  in
          Exhibit 8.1)










                            SIGNATURE



     Pursuant to the requirements of the Securities Exchange  Act
of  1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.


                                        AMR CORPORATION



                                        /s/ Charles D. MarLett
                                        Charles D. MarLett
                                        Corporate Secretary



Dated:  November 21, 2005






                          EXHIBIT INDEX


Exhibit        Description


1.1       Underwriting Agreement dated November 17, 2005  between
          AMR Corporation and UBS Securities LLC

5.1       Opinion of Debevoise & Plimpton LLP

8.1       Opinion of Debevoise & Plimpton LLP

23.1      Consent of Debevoise & Plimpton LLP (contained in
          Exhibit 5.1)

23.2      Consent  of  Debevoise & Plimpton  LLP  (contained  in
          Exhibit 8.1)